Nrc Health Revenue Growth Rates (NRC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Nrc Health  (NASDAQ: NRC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

NRC's Revenue Growth by Quarter and Year

Nrc Health's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NRC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 35.39
1st Quarter March 34.80
FY 70.19

NRCs Annual Revenue
Nrc Health's Revenue in the fiscal year 2025 $ 137.39 millions
Nrc Health's Revenue in the fiscal year 2024 $ 143.06 millions
Nrc Health's Revenue in the fiscal year 2023 $ 148.58 millions
Nrc Health's Revenue in the fiscal year 2022 $ 151.57 millions
Nrc Health's Revenue in the fiscal year 2021 $ 147.95 millions




NRC Revenue second quarter 2026 Y/Y Growth Comment
Nrc Health reported Revenue growth of 3.97% year on year in the second quarter 2026, to $ 35.39 millions, this is lower than Nrc Health's recent average Revenue growth of 8.12%.

Looking into second quarter 2026 results within Medical Laboratories industry 24 other companies have achieved higher Revenue growth. While Nrc Health' s Revenue increase of 3.97% ranks overall at the positon no. 2581 in the second quarter 2026.


NRC Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -4.66 % -2.87 % -0.37 %
3rd Quarter September - -3.38 % -5.61 % 0.69 %
2nd Quarter June 3.97 % -2.8 % -3.15 % -3.03 %
1st Quarter March 3.73 % -4.98 % -3.18 % -5.12 %
FY   - -3.96 % -3.72 % -

Financial Statements
Nrc Health's second quarter 2026 Revenue $ 35.39 millions NRC's Income Statement
Nrc Health's second quarter 2025 Revenue $ 34.04 millions Quarterly NRC's Income Statement


NRC Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 1.68 % 3.04 % 0.13 %
3rd Quarter September - 1.67 % 2.28 % 4.95 %
2nd Quarter June 1.7 % 1.46 % -0.82 % -0.85 %
1st Quarter March -1.11 % -9.1 % -7.08 % -4.38 %
FY (Year on Year)   - -3.96 % -3.72 % -


Back to NRC Growth rate Comparisons >> Back to NRC Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #25
Healthcare Sector #371
Overall #2581

Revenue Y/Y Growth Statistics
High Average Low
125.52 % 8.12 % -48.67 %
(Mar 31 2017)   (Dec 31 2015)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #25
Healthcare Sector #371
Overall #2581
Revenue Y/Y Growth Statistics
High Average Low
125.52 % 8.12 % -48.67 %
(Mar 31 2017)   (Dec 31 2015)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Nrc Health's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
13.55 % -0.84 % -100 %
(Mar 31 2014)  


NRC's II. Quarter Q/Q Revenue Comment
Nrc Health achieved in the II. Quarter 2026 above company average sequential Revenue growth of 1.7%, to $ 35.39 millions, from $34.80 millions in the first quarter.
NRC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Laboratories industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Nrc Health's Revenue growth quarter on quarter, overall rank is 1448.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #198
Overall #1448
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #12
Healthcare Sector #198
Overall #1448
Revenue Q/Q Growth Statistics
High Average Low
13.55 % -0.84 % -100 %
(Mar 31 2014)  


NRC's II. Quarter Q/Q Revenue Comment
Nrc Health achieved in the II. Quarter 2026 above company average sequential Revenue growth of 1.7%, to $ 35.39 millions, from $34.80 millions in the first quarter.
NRC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Laboratories industry 11 other companies have achieved higher Revenue quarter on quarter growth. While Nrc Health's Revenue growth quarter on quarter, overall rank is 1448.


Nrc Health's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 140.00 $ 138.64 $ 137.39 $ 139.10 $ 140.32
Y / Y Revenue Growth (TTM) -0.23 % -1.88 % -3.96 % -3.5 % -4.08 %
Year on Year Revenue Growth Overall Ranking # 2804 # 2119 # 1889 # 2436 # 1981
Seqeuential Revenue Change (TTM) 0.98 % 0.91 % -1.23 % -0.86 % -0.7 %
Seq. Revenue Growth (TTM) Overall Ranking # 2581 # 2312 # 1725 # 2313 # 1936


Cumulative Revenue growth Comment
Nrc Health showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Nrc Health's annual Revenue decline would be -0.23% year on year to $140 millions.

In the Healthcare sector 394 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2119 to 2804.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 25
Healthcare Sector # 395
Overall # 2804

Revenue TTM Y/Y Growth Statistics
High Average Low
125.52 %
 8.12 %
-48.67 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 371
S&P 500 # 2581
Cumulative Revenue growth Comment
Nrc Health showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Nrc Health's annual Revenue drop would be -0.23% year on year to $140 millions.

In the Healthcare sector 394 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2119 to 2804.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 25
Healthcare Sector # 395
Overall # 2804

Revenue TTM Y/Y Growth Statistics
High Average Low
125.52 %
8.12 %
-48.67 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 371
S&P 500 # 2581




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NRC's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Tenet Healthcare Corp6.77%$ 6.773 millions
Henry Schein Inc 6.73%$ 6.728 millions
Collegium Pharmaceutical Inc 6.67%$ 6.668 millions
Mallinckrodt Plc6.62%$ 6.617 millions
Johnson and Johnson6.60%$ 6.600 millions
Prestige Consumer Healthcare Inc 6.57%$ 6.569 millions
Msa Safety Inc6.25%$ 6.252 millions
Pacira Biosciences inc 6.24%$ 6.240 millions
Globus Medical Inc 5.94%$ 5.940 millions
Labcorp Holdings Inc 5.78%$ 5.778 millions
Tandem Diabetes Care Inc 5.77%$ 5.768 millions
Bristol myers Squibb Company5.74%$ 5.738 millions
Haemonetics Corporation5.65%$ 5.646 millions
Progyny Inc 5.58%$ 5.584 millions
Cytek Biosciences Inc 5.57%$ 5.566 millions
Amphastar Pharmaceuticals Inc 5.44%$ 5.441 millions
Becton Dickinson And Company5.44%$ 5.438 millions
Bruker Corporation5.22%$ 5.220 millions
Davita Inc 5.17%$ 5.165 millions
Park Dental Partners Inc 5.10%$ 5.102 millions
Lumexa Imaging Holdings Inc 5.08%$ 5.076 millions
Merck and Co Inc 5.07%$ 5.068 millions
Cv Sciences Inc 4.96%$ 4.958 millions
Viatris Inc 4.88%$ 4.877 millions
Fulgent Genetics Inc 4.86%$ 4.855 millions
Zimmer Biomet Holdings Inc 4.80%$ 4.799 millions
Mettler toledo International Inc 4.48%$ 4.485 millions
Phibro Animal Health Corporation4.40%$ 4.405 millions
Align Technology inc 4.35%$ 4.355 millions
Opko Health Inc 4.32%$ 4.319 millions


About Nrc Health Revenue Growth Rates (NRC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Nrc Health (CIK 70487).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-025624
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Nrc Health’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.